An analysis of monopoly's effect on Iraqi consumer health and the standard of dietary supplements and health foods
DOI:
https://doi.org/10.56967/ejfb2026849Keywords:
monopoly, consumer health, dietary supplements, health foods, market regulationAbstract
Monopolistic practices in Iraq’s dietary supplement and health food markets have created a dual burden: rising prices and declining quality. These dynamics limit consumer access to essential nutrients and compromise public health outcomes. Dietary supplements and fortified health foods are essential in preventing deficiencies and addressing gaps in nutrition, especially in fragile health systems such as Iraq’s, where decades of conflict and economic sanctions have undermined food security and health infrastructure. Yet, monopolistic control by a handful of distributors has led to inflated costs, restricted availability, and potential risks of counterfeit or substandard products.
This study evaluates the effects of monopolistic structures on consumer health by examining the availability, pricing, and quality of dietary supplements and health foods in Iraq. Employing a mixed methods approach, it combines quantitative price analysis with qualitative interviews to capture consumer experiences and expert insights. Findings are expected to reveal significant disparities in accessibility and quality when compared with international standards.
The study contributes to both academic discourse and public policy by filling a critical knowledge gap about how monopolistic practices in Iraq’s health-related markets affect consumer well-being. It offers evidence-based recommendations for policymakers, regulators, and public health stakeholders to promote market fairness, improve access, and safeguard consumer health.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Noorulhuda Fadhil

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an Open Access article distributed under the terms of the creative commons attribution (CC BY) 4.0 international license which permits unrestricted use, distribution, and reproduction in any medium or format, and to alter, transform, or build upon the material, including for commercial use, providing the original author is credited.




